| 1 |
33171493 | miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. | 2021 May 6 |
1 |
| 2 |
32664705 | Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia. | 2020 Jul 12 |
1 |
| 3 |
32791549 | [Current diagnosis and treatment of chronic lymphocytic leukaemia]. | 2020 Aug |
1 |
| 4 |
33154951 | Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. | 2020 Oct 26 |
2 |
| 5 |
31723816 | From Biology to Therapy: The CLL Success Story. | 2019 Apr |
2 |
| 6 |
29978459 | The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment. | 2018 Sep |
2 |
| 7 |
28178345 | PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors. | 2017 |
1 |
| 8 |
28185174 | Current Treatment of Chronic Lymphocytic Leukemia. | 2017 Jan |
2 |
| 9 |
26890007 | State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. | 2016 |
1 |
| 10 |
30512375 | Traiter les formes actives de la maladie. | 2016 Nov |
1 |
| 11 |
25080849 | B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. | 2015 Mar |
1 |
| 12 |
25632006 | Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells. | 2015 Mar 1 |
1 |